8-K
Current Report
Akebia Therapeutics, Inc. Filed Acc 0001628280-23-019654
Material agreement · Regulation FD disclosure
- Item 1.01 Entry into a material definitive agreement
- Item 7.01 Regulation FD disclosure
From the SEC's structured data for this filing
Loading akba-20230524.htm…